Follow this preprint
REACT-1 round 15 final report: Increased breakthrough SARS-CoV-2 infections among adults who had received two doses of vaccine, but booster doses and first doses in children are providing important protection
View ORCID ProfileMarc Chadeau-Hyam, View ORCID ProfileOliver Eales, View ORCID ProfileBarbara Bodinier, View ORCID ProfileHaowei Wang, View ORCID ProfileDavid Haw, View ORCID ProfileMatthew Whitaker, View ORCID ProfileCaroline E. Walters, Jakob Jonnerby, View ORCID ProfileChristina Atchison, View ORCID ProfilePeter J. Diggle, View ORCID ProfileAndrew J. Page, View ORCID ProfileDeborah Ashby, View ORCID ProfileWendy Barclay, Graham Taylor, View ORCID ProfileGraham Cooke, View ORCID ProfileHelen Ward, View ORCID ProfileAra Darzi, View ORCID ProfileChristl A. Donnelly, View ORCID ProfilePaul Elliott
doi: https://doi.org/10.1101/2021.12.14.21267806
Now published in eClinicalMedicine doi: 10.1016/j.eclinm.2022.101419
Marc Chadeau-Hyam
1School of Public Health, Imperial College London, UK
2MRC Centre for Environment and Health, School of Public Health, Imperial College London, UK
Oliver Eales
1School of Public Health, Imperial College London, UK
3MRC Centre for Global infectious Disease Analysis and Jameel Institute, Imperial College London, UK
Barbara Bodinier
1School of Public Health, Imperial College London, UK
2MRC Centre for Environment and Health, School of Public Health, Imperial College London, UK
Haowei Wang
1School of Public Health, Imperial College London, UK
3MRC Centre for Global infectious Disease Analysis and Jameel Institute, Imperial College London, UK
David Haw
1School of Public Health, Imperial College London, UK
3MRC Centre for Global infectious Disease Analysis and Jameel Institute, Imperial College London, UK
Matthew Whitaker
1School of Public Health, Imperial College London, UK
2MRC Centre for Environment and Health, School of Public Health, Imperial College London, UK
Caroline E. Walters
1School of Public Health, Imperial College London, UK
3MRC Centre for Global infectious Disease Analysis and Jameel Institute, Imperial College London, UK
Jakob Jonnerby
1School of Public Health, Imperial College London, UK
3MRC Centre for Global infectious Disease Analysis and Jameel Institute, Imperial College London, UK
Christina Atchison
1School of Public Health, Imperial College London, UK
Peter J. Diggle
4CHICAS, Lancaster Medical School, Lancaster University, UK and Health Data Research, UK
Andrew J. Page
5Quadram Institute, Norwich, UK
Deborah Ashby
1School of Public Health, Imperial College London, UK
Wendy Barclay
6Department of Infectious Disease, Imperial College London, UK
Graham Taylor
6Department of Infectious Disease, Imperial College London, UK
Graham Cooke
6Department of Infectious Disease, Imperial College London, UK
7Imperial College Healthcare NHS Trust, UK
8National Institute for Health Research Imperial Biomedical Research Centre, UK
Helen Ward
1School of Public Health, Imperial College London, UK
7Imperial College Healthcare NHS Trust, UK
8National Institute for Health Research Imperial Biomedical Research Centre, UK
Ara Darzi
7Imperial College Healthcare NHS Trust, UK
8National Institute for Health Research Imperial Biomedical Research Centre, UK
9Institute of Global Health Innovation, Imperial College London, UK
Christl A. Donnelly
1School of Public Health, Imperial College London, UK
3MRC Centre for Global infectious Disease Analysis and Jameel Institute, Imperial College London, UK
10Department of Statistics, University of Oxford, UK
Paul Elliott
1School of Public Health, Imperial College London, UK
2MRC Centre for Environment and Health, School of Public Health, Imperial College London, UK
7Imperial College Healthcare NHS Trust, UK
8National Institute for Health Research Imperial Biomedical Research Centre, UK
11Health Data Research (HDR) UK, Imperial College London, UK
12UK Dementia Research Institute, Imperial College London, UK

Posted December 16, 2021.
REACT-1 round 15 final report: Increased breakthrough SARS-CoV-2 infections among adults who had received two doses of vaccine, but booster doses and first doses in children are providing important protection
Marc Chadeau-Hyam, Oliver Eales, Barbara Bodinier, Haowei Wang, David Haw, Matthew Whitaker, Caroline E. Walters, Jakob Jonnerby, Christina Atchison, Peter J. Diggle, Andrew J. Page, Deborah Ashby, Wendy Barclay, Graham Taylor, Graham Cooke, Helen Ward, Ara Darzi, Christl A. Donnelly, Paul Elliott
medRxiv 2021.12.14.21267806; doi: https://doi.org/10.1101/2021.12.14.21267806
Now published in eClinicalMedicine doi: 10.1016/j.eclinm.2022.101419
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (412)
- Allergy and Immunology (726)
- Anesthesia (214)
- Cardiovascular Medicine (3112)
- Dermatology (263)
- Emergency Medicine (463)
- Epidemiology (13049)
- Forensic Medicine (13)
- Gastroenterology (862)
- Genetic and Genomic Medicine (4871)
- Geriatric Medicine (449)
- Health Economics (751)
- Health Informatics (3072)
- Health Policy (1109)
- Hematology (410)
- HIV/AIDS (963)
- Medical Education (453)
- Medical Ethics (120)
- Nephrology (502)
- Neurology (4641)
- Nursing (247)
- Nutrition (689)
- Oncology (2395)
- Ophthalmology (679)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (307)
- Palliative Medicine (88)
- Pathology (516)
- Pediatrics (1243)
- Primary Care Research (522)
- Public and Global Health (7206)
- Radiology and Imaging (1607)
- Respiratory Medicine (944)
- Rheumatology (461)
- Sports Medicine (403)
- Surgery (514)
- Toxicology (65)
- Transplantation (222)
- Urology (190)